Pure Global

Blazer™ Dx-20 Catheter Bidirectional Steerable Diagnostic Catheter; Polaris X™ Unidirectional Steerable Diagnostic Catheter (sipas listes bashkengjitur) - Albania Medical Device Registration

Access comprehensive regulatory information for Blazer™ Dx-20 Catheter Bidirectional Steerable Diagnostic Catheter; Polaris X™ Unidirectional Steerable Diagnostic Catheter (sipas listes bashkengjitur) in the Albania medical device market through Pure Global AI's free database. This III medical device is manufactured by Boston Scientific Corporation 300 Boston Scientific Way Marlborough, MA 01752 USA. The device was registered on October 03, 2022.

This page provides complete registration details including product model (Blazer™ Dx-20 Catheter Bidirectional Steerable Diagnostic Catheter; Polaris X™ Unidirectional Steerable Diagnostic Catheter (sipas listes bashkengjitur)), manufacturer information, risk classification, and regulatory compliance data from the official Albania medical device database. Pure Global AI offers free access to Albania's medical device registry, helping global MedTech companies navigate Albania regulations efficiently.

Free Database
Powered by Pure Global AI
Albania Official Data
III
Blazer™ Dx-20 Catheter Bidirectional Steerable Diagnostic Catheter; Polaris X™ Unidirectional Steerable Diagnostic Catheter (sipas listes bashkengjitur)
Albania Medical Device Registration
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Information

Katetere diagnostikuese qe munf te perfshijne ose nje mekanizem drejtues me dy kahe ose nje kah.

Device Classification
Risk Class
III
Product Model
Blazer™ Dx-20 Catheter Bidirectional Steerable Diagnostic Catheter; Polaris X™ Unidirectional Steerable Diagnostic Catheter (sipas listes bashkengjitur)
Product Name
Blazer™ Dx-20 Catheter Bidirectional Steerable Diagnostic Catheter; Polaris X™ Unidirectional Steerable Diagnostic Catheter (sipas listes bashkengjitur)
Registration Information
Registration Date
October 03, 2022
Analysis ID
12860